Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Merck Animal Health has acquired a controlling stake in Vallée S.A.
Consumer & Retail | Healthcare

Merck Animal Health has acquired a controlling stake in Vallée S.A.

Merck Animal Health has acquired a controlling stake in Vallée S.A.

Learn more
SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Centro Diagnóstico Boris Berenstein has been acquired by DASA
Healthcare

Centro Diagnóstico Boris Berenstein has been acquired by DASA

The Berenstein family has sold Centro Diagnóstico Boris Berenstein (CDBB) to Diagnósticos da America S.A. (DASA).

Learn more
“The difficult decision-making process to sell the company took a few years, and the choice of the team to lead the negotiation was a very important step for the Berenstein Family. It took a few years of dedication, comings and goings, and a pandemic, but they brought us competence and confidence so that the deal was closed. Congratulations on the excellent work done.”

Boris Berenstein

Former Owner and President, Centro Diagnóstico Boris Berenstein

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=BR&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Reshaping industries: M&A highlights and strategic vision

QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.

Learn more

Talk to our local advisors

Irajá Guimarães

Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Harold Takahashi

Partner
São Paulo, Brazil
Oaklins Fortezza Partners

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Dino Theodorou

Director
Johannesburg, South Africa
Oaklins Grindrod

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital